# Immunocore Holdings plc: Form 8-K, filed Feb 2, 2024

- Company: [Immunocore Holdings plc](/companies/imcr.md) (CIK 1671927)
- Form: 8-K
- Filed: 2024-02-02
- Accepted by EDGAR: Feb 2, 2024, 21:05 ET
- Period: 2024-01-30
- Accession: 0001140361-24-005309
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1671927/000114036124005309/ef20020523_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1671927/000114036124005309/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1671927/000114036124005309/ef20020523_8k.htm

Filed Feb 2, 2024.
Source: SEC EDGAR, the filing index for accession 0001140361-24-005309. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.